{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:33:58Z","timestamp":1780727638536,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001951","name":"Angelman Syndrome Foundation","doi-asserted-by":"publisher","award":["Angelman Syndrome Foundation"],"award-info":[{"award-number":["Angelman Syndrome Foundation"]}],"id":[{"id":"10.13039\/100001951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009726","name":"Foundation for Angelman Syndrome Therapeutics","doi-asserted-by":"publisher","award":["Foundation for Angelman Syndrome Therapeutics"],"award-info":[{"award-number":["Foundation for Angelman Syndrome Therapeutics"]}],"id":[{"id":"10.13039\/100009726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The Bayley Scales of Infant and Toddler Development- 4th Edition (Bayley-4) and Vineland Adaptive Behavior Scales \u2013 3rd Edition (Vineland-3) are outcome measures often considered as primary endpoints in clinical trials for Angelman syndrome (AS). We explored barriers encountered when administering these instruments to individuals with AS and associated guidance for their use in trials and research studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We interviewed nine clinicians who have administered the Bayley-4 and\/or the Vineland-3 to individuals with AS and analyzed their transcripts using a quasi-deductive analysis approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Barriers to administering the Bayley-4 included participant\u2019s lack of interest, overexcitement, emotional impact on caregiver, the mental workload of administering the Bayley-4, and environmental factors (e.g., administration setting). Barriers to administering the Vineland-3 included determining the most appropriate start point, emotional impact on caregiver, distractions, conflicting answers from two caregivers, and the mental workload of administering the Vineland-3. Participants provided potential solutions to each barrier. Lastly, we identified overarching item-level concerns for both the Bayley-4 (i.e., administration challenges, items not aligned with abilities) and the Vineland-3 (i.e., misalignment of assessment criteria and condition characteristics, limitations in observation and contextual understanding, requires specialized training).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Clinical trials often rely on the Bayley-4 and Vineland-3 assessments as outcome measures, yet our identified barriers threaten their validity. The associated solutions provide a path forward for improving administration of the Bayley-4 and Vineland-3 in clinical practice, research, and future trials focused on individuals with AS and other intellectual and developmental disabilities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03817-x","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:37:54Z","timestamp":1748983074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Using the Bayley-4 and Vineland-3 in Angelman syndrome: barriers, solutions, and challenging items"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5624-6083","authenticated-orcid":false,"given":"Sean N.","family":"Halpin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8640-8992","authenticated-orcid":false,"given":"Sarah Nelson","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2305-7187","authenticated-orcid":false,"given":"Angela","family":"Gwaltney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0938-0591","authenticated-orcid":false,"given":"Anjali","family":"Sadhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5423-1790","authenticated-orcid":false,"given":"Katherine C.","family":"Okoniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2693-5616","authenticated-orcid":false,"given":"Anne C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"3","key":"3817_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/ajmg.1320590331","volume":"59","author":"M Kyllerman","year":"1995","unstructured":"Kyllerman M. On the prevalence of Angelman syndrome. Am J Med Genet. 1995;59(3):405. author reply 3\u20134.","journal-title":"Am J Med Genet"},{"issue":"3","key":"3817_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ajmg.1320600317","volume":"60","author":"MB Petersen","year":"1995","unstructured":"Petersen MB, Br\u00f8ndum-Nielsen K, Hansen LK, Wulff K. Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: estimated prevalence rate in a Danish County. Am J Med Genet. 1995;60(3):261\u20132.","journal-title":"Am J Med Genet"},{"key":"3817_CR3","first-page":"1","volume":"34","author":"C Williams","year":"2009","unstructured":"Williams C, Peters SU, Calculator S. Facts about Angelman syndrome. Angelman Org. 2009;34:1\u201324.","journal-title":"Angelman Org"},{"key":"3817_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/TACG.S57386","volume":"7","author":"LM Bird","year":"2014","unstructured":"Bird LM. Angelman syndrome: review of clinical and molecular aspects. Appl Clin Genet. 2014;7:93\u2013104.","journal-title":"Appl Clin Genet"},{"issue":"7","key":"3817_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/13543784.2021.1939674","volume":"30","author":"T Markati","year":"2021","unstructured":"Markati T, Duis J, Servais L. Therapies in preclinical and clinical development for Angelman syndrome. Expert Opin Investig Drugs. 2021;30(7):709\u201320.","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"3817_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40271-018-0323-7","volume":"12","author":"JC Grieco","year":"2019","unstructured":"Grieco JC, Romero B, Flood E, Cabo R, Visootsak J. A conceptual model of Angelman syndrome and review of relevant clinical outcomes assessments (COAs). Patient. 2019;12(1):97\u2013112.","journal-title":"Patient"},{"issue":"7","key":"3817_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/DBP.0b013e3181ee408e","volume":"31","author":"JK Gentile","year":"2010","unstructured":"Gentile JK, Tan WH, Horowitz LT, Bacino CA, Skinner SA, Barbieri-Welge R, et al. A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations. J Dev Behav Pediatr. 2010;31(7):592\u2013601.","journal-title":"J Dev Behav Pediatr"},{"issue":"7","key":"3817_CR8","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1038\/s41380-020-0858-6","volume":"26","author":"M Keute","year":"2021","unstructured":"Keute M, Miller MT, Krishnan ML, Sadhwani A, Chamberlain S, Thibert RL, et al. Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment. Mol Psychiatry. 2021;26(7):3625\u201333.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"3817_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s10803-020-04861-1","volume":"53","author":"A Sadhwani","year":"2023","unstructured":"Sadhwani A, Wheeler A, Gwaltney A, Peters SU, Barbieri-Welge RL, Horowitz LT, et al. Developmental skills of individuals with Angelman syndrome assessed using the Bayley-III. J Autism Dev Disord. 2023;53(2):720\u201337.","journal-title":"J Autism Dev Disord"},{"issue":"6","key":"3817_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1352\/1944-7558-125.6.434","volume":"125","author":"C DiStefano","year":"2020","unstructured":"DiStefano C, Sadhwani A, Wheeler AC. Comprehensive assessment of individuals with significant levels of intellectual disability: challenges, strategies, and future directions. Am J Intellect Dev Disabil. 2020;125(6):434\u201348.","journal-title":"Am J Intellect Dev Disabil"},{"key":"3817_CR11","doi-asserted-by":"crossref","unstructured":"Bayley N, Alyward GP. Bayley scales of infant and toddler development. 4th ed. Pearson 2019.","DOI":"10.1007\/978-3-319-57111-9_1522"},{"issue":"3","key":"3817_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bpsgos.2021.05.003","volume":"1","author":"JF Hipp","year":"2021","unstructured":"Hipp JF, Frohlich J, Keute M, Tan WH, Bird LM. Electrophysiological abnormalities in Angelman syndrome correlate with symptom severity. Biol Psychiatry Glob Open Sci. 2021;1(3):201\u20139.","journal-title":"Biol Psychiatry Glob Open Sci"},{"issue":"6","key":"3817_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ajmg.a.61140","volume":"179","author":"A Sadhwani","year":"2019","unstructured":"Sadhwani A, Willen JM, LaVallee N, Stepanians M, Miller H, Peters SU, et al. Maladaptive behaviors in individuals with Angelman syndrome. Am J Med Genet A. 2019;179(6):983\u201392.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"3817_CR14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/ajmg.a.38457","volume":"176","author":"WH Tan","year":"2018","unstructured":"Tan WH, Bird LM, Sadhwani A, Barbieri-Welge RL, Skinner SA, Horowitz LT, et al. A randomized controlled trial of Levodopa in patients with Angelman syndrome. Am J Med Genet A. 2018;176(5):1099\u2013107.","journal-title":"Am J Med Genet A"},{"key":"3817_CR15","doi-asserted-by":"crossref","unstructured":"Gwaltney A, Potter SN, Peters SU, Barbieri-Welge RL, Horowitz LT, Noll LM, et al. Adaptive Skills of Individuals with Angelman Syndrome Assessed Using the Vineland Adaptive Behavior Scales, 2nd Edition. J Autism Dev Disord. 2023.","DOI":"10.1007\/s10803-023-06090-8"},{"issue":"12","key":"3817_CR16","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1093\/jn\/nxab284","volume":"151","author":"RP Carson","year":"2021","unstructured":"Carson RP, Herber DL, Pan Z, Phibbs F, Key AP, Gouelle A, et al. Nutritional formulation for patients with Angelman syndrome: A randomized, Double-Blind, Placebo-Controlled study of exogenous ketones. J Nutr. 2021;151(12):3628\u201336.","journal-title":"J Nutr"},{"key":"3817_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12883-014-0232-x","volume":"14","author":"JC Grieco","year":"2014","unstructured":"Grieco JC, Ciarlone SL, Gieron-Korthals M, Schoenberg MR, Smith AG, Philpot RM, et al. An open-label pilot trial of Minocycline in children as a treatment for Angelman syndrome. BMC Neurol. 2014;14:232.","journal-title":"BMC Neurol"},{"key":"3817_CR18","unstructured":"Bayley N. Bayley scales of infant and toddler development. The Psychological Corporation. 1969."},{"key":"3817_CR19","unstructured":"Bayley N. Bayley scales of infant and toddler development. 2nd ed. The Psychological Corporation. 1993."},{"key":"3817_CR20","doi-asserted-by":"crossref","unstructured":"Bayley N. Bayley scales of infant and toddler development. 3rd ed. Pearson. 2006.","DOI":"10.1037\/t14978-000"},{"key":"3817_CR21","volume-title":"Vineland adaptive behavior scales","author":"S Sparrow","year":"1984","unstructured":"Sparrow S, Balla D, Cicchetti D. Vineland adaptive behavior scales. Circle Pines, MN: American Guidance Service. 1984."},{"key":"3817_CR22","volume-title":"Vineland adaptive behavior scales: second edition (Vineland II)","author":"S Sparrow","year":"2005","unstructured":"Sparrow S, Cicchetti D, Balla D. Vineland adaptive behavior scales: second edition (Vineland II). Livonia, MN: Pearson Assessments. 2005."},{"key":"3817_CR23","volume-title":"Vineland-3: vineland adaptive behavior scales","author":"S Sparrow","year":"2016","unstructured":"Sparrow S, Cicchetti D, Saulnier C. Vineland-3: vineland adaptive behavior scales. 3rd ed. Minneapolis, MN: Pearson. 2016.","edition":"3"},{"key":"3817_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.rasd.2017.08.002","volume":"41\u201342","author":"LE Miller","year":"2017","unstructured":"Miller LE, Perkins KA, Dai YG, Fein DA. Comparison of parent report and direct assessment of child skills in toddlers. Res Autism Spectr Disord. 2017;41\u201342:57\u201365.","journal-title":"Res Autism Spectr Disord"},{"issue":"8","key":"3817_CR25","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jaac.2011.03.012","volume":"50","author":"S Ozonoff","year":"2011","unstructured":"Ozonoff S, Iosif AM, Young GS, Hepburn S, Thompson M, Colombi C, et al. Onset patterns in autism: correspondence between home video and parent report. J Am Acad Child Adolesc Psychiatry. 2011;50(8):796\u2013e8061.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"3817_CR26","doi-asserted-by":"publisher","first-page":"233339362110129","DOI":"10.1177\/23333936211012990","volume":"8","author":"SN Halpin","year":"2021","unstructured":"Halpin SN, Konomos M, Roulson K. Using applied conversation analysis in patient education. Glob Qual Nurs Res. 2021;8:23333936211012990.","journal-title":"Glob Qual Nurs Res"},{"issue":"2","key":"3817_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3316\/QRJ1102063","volume":"11","author":"H Suri","year":"2011","unstructured":"Suri H. Purposeful sampling in qualitative research synthesis. Qualitative Res J. 2011;11(2):63\u201375.","journal-title":"Qualitative Res J"},{"key":"3817_CR28","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208.","journal-title":"J Biomed Inf"},{"issue":"2","key":"3817_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381.","journal-title":"J Biomed Inf"},{"key":"3817_CR30","unstructured":"Roulston K, Halpin SN. The SAGE Handbook of Qualitative Research Design. 2022 2024\/05\/03. 55 City Road 55 City Road, London: SAGE Publications Ltd. Available from: https:\/\/sk.sagepub.com\/reference\/the-sage-handbook-of-qualitative-research-design"},{"key":"3817_CR31","unstructured":"Patton MQ. Qualitative research & evaluation methods: integrating theory and practice. Sage; 2014."},{"issue":"5 Pt 2","key":"3817_CR32","first-page":"1189","volume":"34","author":"MQ Patton","year":"1999","unstructured":"Patton MQ. Enhancing the quality and credibility of qualitative analysis. Health Serv Res. 1999;34(5 Pt 2):1189\u2013208.","journal-title":"Health Serv Res"},{"issue":"3","key":"3817_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.29333\/ajqr\/14887","volume":"8","author":"SN Halpin","year":"2024","unstructured":"Halpin SN. Inter-coder agreement in qualitative coding: considerations for its use. Am J Qualitative Res. 2024;8(3):23\u201343.","journal-title":"Am J Qualitative Res"},{"issue":"7","key":"3817_CR34","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jval.2017.05.015","volume":"20","author":"K Benjamin","year":"2017","unstructured":"Benjamin K, Vernon MK, Patrick DL, Perfetto E, Nestler-Parr S, Burke L. Patient-Reported outcome and Observer-Reported outcome assessment in rare disease clinical trials: an ISPOR COA emerging good practices task force report. Value Health. 2017;20(7):838\u201355.","journal-title":"Value Health"},{"key":"3817_CR35","unstructured":"Baker SE. R. How many qualitative interviews is enough? Expert voices and early career reflections on sampling and cases in qualitative research. National Centre for Research Methods, Economic and Social Council. 2012."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03817-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03817-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03817-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:38:00Z","timestamp":1748983080000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03817-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03817-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the RTI Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"273"}}